- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
- Video and telephone consultations
- Home chemotherapy
I am a consultant Haematologist at Cambridge University Teaching Hospitals NHS Foundation Trust and a partner in Cambridge Haematology LLP.
I am the Clinical Lead for Lymphoma / Hodgkin Lymphoma and Chronic Lymphocytic Leukaemia (CLL) for Cambridge and the Anglia Cancer Network.
My national appointments include Chair of the UK CLL Forum and Chair of the BCSH Hodgkin Lymphoma Guidelines Panel. I serve on a number of research boards at regional and national level.
Areas of interest
Hodgkin's disease; Leukaemia; Lymphoma; CLL; NHL; anaemia; Haematological oncology
Current NHS consultant posts held
Consultant Haematologist and University Associate Lecturer
Cambridge University Hospitals NHS Trust
University teaching prize
Over 50 publications published in peer reviewed journals including BMJ, New England Journal of Medicine etc
We have excellent outcome data across the board for patients treated with haematological cancers in Cambridge over the last 5+ years from both our NHS and private practice. We are always happy to share this data with patients on request.
- MA, BM, BCh Oxford 1994
- FRCP London 2012
- PhD Leeds 2004
- FRCPath London 2004
Reference number 4122010
- GenesisCare Cancer Centre
- 07:30 - 10:30
- 01223 907600
- Nuffield Health Cambridge Hospital, CB2 8AF
- 08:00 - 12:00
- 01223 513479
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
All of our patients receiving treatment are given a number of contact details for 24 hour access to nursing and consultant staff as required.
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
Diagnostic aspiration and trephine biopsy of bone marrow, including analysis - (5-50)